The whipping post

Nasdaq Climbs; Lowe’s Shines Brightest Among Earnings Reports Nasdaq Climbs; Lowe’s Shines Brightest Among Earnings Reports


U.S. stocks showed mixed performance this morning, with the Nasdaq Composite making a robust advance of 50 points on Tuesday.

As the market opened on Tuesday, the Dow declined marginally by 0.07% to 39,043.13, while the NASDAQ surged by 0.31% to 16,026.43. The S&P 500 also saw gains, rising by 0.10% to 5,074.75.

Utilities sector witnessed a rise of 0.7% on Tuesday, while health care shares experienced a decline of 0.3% in trading.

Standout Performance by Lowe’s Companies Inc

Lowe’s Companies Inc (LOW) exceeded expectations with its fourth-quarter results.

Lowe’s reported fourth-quarter FY23 sales of $18.60 billion, surpassing the analyst consensus of $18.45 billion. The EPS stood at $1.77, beating the consensus of $1.68.

For FY24, Lowe’s anticipates revenue between $84 billion and $85 billion (compared to the Street view of $85.61 billion) and adjusted EPS in the range of $12.00 to $12.30, against the consensus of $12.95. The company projects a decrease of about 2% to 3% in comparable sales for FY24.

Stocks on the Move

Janux Therapeutics, Inc. (JANX) saw a significant increase of 138% to $36.00 following the announcement of updated clinical data for its clinical programs.

Shares of Infobird Co., Ltd (IFBD) surged by 111% to $5.84, amidst marked volatility due to an unexpected delay in its planned reverse stock split revealed on Monday.

Viking Therapeutics, Inc. (VKTX) observed a rise of 79% to $68.93 after the successful accomplishment of its Phase 2 VENTURE trial’s primary and secondary endpoints.

Stocks under Pressure

Minerva Neurosciences, Inc. (NERV) witnessed a significant drop of 58% to $2.84 following the receipt of a Complete Response Letter from the FDA for its New Drug Application.

See also  Why Earnings Season Matters

Shares of Thoughtworks Holding, Inc. (TWKS) plummeted by 35% to $2.9950 after reporting lower-than-expected fourth-quarter financial results and issuing weak guidance.

NRx Pharmaceuticals, Inc. (NRXP) fell by 31% to $0.2930 after announcing a public offering of common stock and investor commitments.

Market Trends in Commodities and Overseas

In commodity trading, oil rose by 0.6% to $78.01, while gold saw a 0.3% increase, reaching $2,045.20.

Silver fell by 0.6% to $22.65 on Tuesday, while copper rose by 0.3% to $3.8440.

European shares exhibited a mostly positive trend, with the eurozone’s STOXX 600 rising by 0.1%. Notably, Germany’s DAX gained 0.5%, while Spain’s IBEX 35 fell by 0.5%.

Insights into Asia Pacific Markets and Economic Indicators

Asian markets closed higher on Tuesday, with Japan’s Nikkei 225 rising marginally by 0.01%, Hong Kong’s Hang Seng Index surging by 0.94%, China’s Shanghai Composite Index climbing by 1.29%, and India’s S&P BSE Sensex gaining 0.4%.

Hong Kong recorded a trade surplus of $3.6 billion in January, a notable shift from a deficit of $25.4 billion a year earlier. Japan’s annual inflation rate slowed to 2.2% in January from 2.6% in the previous month.

Durable goods orders in the U.S. tumbled by 6.1% month-over-month in January, contrasting with a 0.3% decline in December.

House prices showed a modest 0.1% increase as per the FHFA house price index in December, following a 0.4% rise in November. The S&P CoreLogic Case-Shiller 20-city home price index exhibited a solid 6.1% year-over-year growth in December.